Bioequivalence of TF3 and TF2 and Effect of Food on the PK of Tepotinib
Clinical trial NCT03629223 · COMPLETED
Trial details
- NCT number
- NCT03629223
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-01-25
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.